Pharmaceutical representatives

BMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7061.881a (Published 05 October 1996) Cite this as: BMJ 1996;313:881

Guidelines exist on making effective use of time spent with representatives

  1. Richard Tiner, Director
  1. Department of Medicine, Association of the British Pharmaceutical Industry, London SW1A 2DY

    EDITOR,—Allen F Shaughnessy and David C Slawson give an American view of how to get the best from a medical representative.1 This is something that the Association of the British Pharmaceutical Industry would encourage all doctors to do. The association recognises that a doctor's time is valuable and has many demands on it; therefore it is important that it is not wasted.

    Doctors make a prescribing decision on the basis of a firm knowledge of the patient or the disease process being treated. Also …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription